risperidone has been researched along with As If Personality in 5 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This 12-month, prospective, observational study investigated factors associated with symptomatic remission (total YMRS score < or =12) and full clinical recovery (sustained reduction in CGI-BP-S overall score) in bipolar disorder during treatment with atypical antipsychotics (predominantly olanzapine, risperidone and quetiapine; alone or in combination with a psychotropic such as lithium or valproate) in actual clinical practice." | 3.76 | Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics. ( Badr, MG; D'yachkova, Y; Dikeos, D; Fábián, Z; Harrison, G; Hudiţă, C; Okasha, T; Pesek, MB; Tapia-Paniagua, G; Treuer, T; Yang, F, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dikeos, D | 1 |
| Badr, MG | 1 |
| Yang, F | 1 |
| Pesek, MB | 1 |
| Fábián, Z | 1 |
| Tapia-Paniagua, G | 1 |
| Hudiţă, C | 1 |
| Okasha, T | 1 |
| D'yachkova, Y | 1 |
| Harrison, G | 1 |
| Treuer, T | 1 |
| Koenigsberg, HW | 1 |
| Reynolds, D | 1 |
| Goodman, M | 1 |
| New, AS | 1 |
| Mitropoulou, V | 1 |
| Trestman, RL | 1 |
| Silverman, J | 1 |
| Siever, LJ | 1 |
| Machida, N | 1 |
| Shiotsuka, S | 1 |
| Semba, J | 1 |
| Lauwers, K | 1 |
| de Hert, M | 1 |
| de Rijdt, L | 1 |
| Peuskens, J | 1 |
| Buckley, PF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder[NCT00158028] | 25 participants (Actual) | Interventional | 1995-11-30 | Completed | |||
| A D1 Agonist For Working Memory Enhancement In The Schizophrenia Spectrum[NCT02507206] | Phase 2 | 120 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for risperidone and As If Personality
| Article | Year |
|---|---|
Broad therapeutic uses of atypical antipsychotic medications.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Child; Child Development Disorders, P | 2001 |
1 trial available for risperidone and As If Personality
| Article | Year |
|---|---|
Risperidone in the treatment of schizotypal personality disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Comorbidity; Double-Blind Method; Drug Administration Sched | 2003 |
Risperidone in the treatment of schizotypal personality disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Comorbidity; Double-Blind Method; Drug Administration Sched | 2003 |
Risperidone in the treatment of schizotypal personality disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Comorbidity; Double-Blind Method; Drug Administration Sched | 2003 |
Risperidone in the treatment of schizotypal personality disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Comorbidity; Double-Blind Method; Drug Administration Sched | 2003 |
3 other studies available for risperidone and As If Personality
| Article | Year |
|---|---|
Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Diagnostic and Statisti | 2010 |
[Case of obsessive-compulsive disorder associated with neuroleptics-induced deficit syndrome (NIDS): successfully treated by discontinuation of neuroleptics followed by SSRI].
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Fluvoxamine; Haloperidol; Human | 2005 |
[Glucose abnormalities in a 14-year old patient treated with a second generation antipsychotic].
Topics: Adolescent; Antipsychotic Agents; Blood Glucose; Diabetes Mellitus; Humans; Male; Personality Disord | 2006 |